EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Blocking the IL‑6 pathway to treat immune checkpoint inhibitor‑induced inflammatory arthritis (Review)

Liwen Zhao, Chuting Feng, Yong-Jing Gao, Tianzhen He

Molecular Medicine Reports · 2025

DOI: 10.3892/mmr.2025.13615 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, 2025. Verfasst von Liwen Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pain Medicine and Special Environmental Medicine, Co‑innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu 226019…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Interleukin-6, Signal Transduction, Arthritis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incorporation of immune checkpoint inhibitors (ICIs) into cancer treatment has revolutionized oncology, providing marked advantages in managing various types of cancer. Nevertheless, the increasing use of ICIs has led to the emergence of immune‑related side effects, including autoimmune diseases such as inflammatory arthritis. IL‑6 signaling is crucial in the development of inflammatory arthritis and is linked to both the benefits and adverse effects of ICIs. The present review summarizes the latest progress in the IL‑6 pathway in inflammatory arthritis and discusses the therapeutic potential of IL‑6 pathway inhibitors for ICI‑induced inflammatory arthritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsInterleukin-6Signal TransductionArthritisInterleukin-6 InhibitorsHumansAnimalsNeoplasms

Stichwörter der Autor:innen

IL‑6immune checkpoint inhibitor‑induced inflammatory arthritisimmune‑related adverse eventstherapeutic potential

Substanzen

Immune Checkpoint InhibitorsInterleukin-6Interleukin-6 Inhibitors

Autor:innen und Institutionen

  • Institute of Pain Medicine and Special Environmental Medicine, Co‑innovation Center of Neuroregeneration, Nantong University, Nantong, Jiangsu 226019, P.R. China.

Zitieren

APA

Zhao, L., Feng, C., Gao, Y. J., & He, T. (2025). Blocking the IL‑6 pathway to treat immune checkpoint inhibitor‑induced inflammatory arthritis (Review). Molecular Medicine Reports. https://doi.org/10.3892/mmr.2025.13615

Vancouver

Zhao L, Feng C, Gao YJ, He T. Blocking the IL‑6 pathway to treat immune checkpoint inhibitor‑induced inflammatory arthritis (Review). Molecular Medicine Reports. 2025. doi:10.3892/mmr.2025.13615

BibTeX
@article{Zhao2025,
  author = {Zhao, Liwen and Feng, Chuting and Gao, Yong-Jing and He, Tianzhen},
  title = {Blocking the IL‑6 pathway to treat immune checkpoint inhibitor‑induced inflammatory arthritis (Review)},
  journal = {Molecular Medicine Reports},
  year = {2025},
  doi = {10.3892/mmr.2025.13615}
}
Kostenlos starten →